GLOSSARY ENTRY (DERIVED FROM QUESTION BELOW) | ||||||
---|---|---|---|---|---|---|
|
15:48 Dec 17, 2001 |
English to Spanish translations [PRO] Medical | |||||
---|---|---|---|---|---|
|
| ||||
| Selected response from: Guido Castañeda Spain Local time: 03:36 | ||||
Grading comment
|
Summary of answers provided | ||||
---|---|---|---|---|
5 +4 | criterio (final) de valoración |
| ||
5 +2 | Endpoint |
| ||
5 +2 | Para cerrar esta discusión.... |
| ||
5 +1 | To endpoint or not to endpoint..... |
| ||
4 +1 | variable principal de valoración / variables sometidas a estudio / objetivos |
| ||
5 | punto terminal |
| ||
4 +1 | detalle |
| ||
4 +1 | Un comentario más |
| ||
4 +1 | usuario final |
| ||
4 | la conclusión de un estudio médico/ investigación médica |
| ||
4 | criterio (final) de valoración |
| ||
4 -1 | variable de salida |
|
la conclusión de un estudio médico/ investigación médica Explanation: it could also be el punto conclusivo de ...... it is a bit difficult to provide you with a precise answer when there is very little context. |
| |
Login to enter a peer comment (or grade) |
Endpoint Explanation: Siobbhan, "Endpoint" se entiende bien en la comunidad médica argentina. Nosotros hemos conducido varios "multicenter clinical trials" con varias ciudades argentinas, y en el protocolo del estudio "endpoint" gral.mente se deja tal cual. Suerte Elena -------------------------------------------------- Note added at 2001-12-17 17:27:57 (GMT) -------------------------------------------------- Estas son algunas de nuestras publicaciones donde se comprende bien la diferencia entre "endpoint" y "outcome measurement/variable". Se pueden encontrar también en el Web site de PubMed, tipeando "sgarbossa eb & outcome": 1: Barbagelata A, Califf RM, Sgarbossa EB, Goodman SG, Knight D, Mark DB, Granger CB, Agranatti DA, Mautner B, Ohman EM, Suarez LD, Armstrong PW, Gates K, Wagner GS. Related Articles Use of resources, quality of life, and clinical outcomes in patients with and without new Q waves after thrombolytic therapy for acute myocardial infarction (from the GUSTO-I trial). Am J Cardiol. 2000 Jul 1;86(1):24-9. PMID: 10867087 [PubMed - indexed for MEDLINE] 2: Sgarbossa EB, Black IW, Maloney JD. Related Articles Pacemakers, defibrillators, and direct current cardioversion. Curr Opin Cardiol. 1993 Jan;8(1):27-38. Review. PMID: 10148086 [PubMed - indexed for MEDLINE] 3: Pinski SL, Sgarbossa EB, Ching E, Trohman RG. Related Articles A comparison of 50-J versus 100-J shocks for direct-current cardioversion of atrial flutter. Am Heart J. 1999 Mar;137(3):439-42. PMID: 10047623 [PubMed - indexed for MEDLINE] 4: Lamas GA, Orav EJ, Stambler BS, Ellenbogen KA, Sgarbossa EB, Huang SK, Marinchak RA, Estes NA 3rd, Mitchell GF, Lieberman EH, Mangione CM, Goldman L. Related Articles Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker Selection in the Elderly Investigators. N Engl J Med. 1998 Apr 16;338(16):1097-104. PMID: 9545357 [PubMed - indexed for MEDLINE] 5: Goodman SG, Langer A, Ross AM, Wildermann NM, Barbagelata A, Sgarbossa EB, Wagner GS, Granger CB, Califf RM, Topol EJ, Simoons ML, Armstrong PW. Related Articles Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators. Circulation. 1998 Feb 10;97(5):444-50. PMID: 9490238 [PubMed - indexed for MEDLINE] 6: Sgarbossa EB, Pinski SL, Topol EJ, Califf RM, Barbagelata A, Goodman SG, Gates KB, Granger CB, Miller DP, Underwood DA, Wagner GS. Related Articles Acute myocardial infarction and complete bundle branch block at hospital admission: clinical characteristics and outcome in the thrombolytic era. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA [tissue-type plasminogen activator] for Occluded Coronary Arteries. J Am Coll Cardiol. 1998 Jan;31(1):105-10. PMID: 9426026 [PubMed - indexed for MEDLINE] 7: Barbagelata A, Califf RM, Sgarbossa EB, Goodman SG, Stebbins AL, Granger CB, Suarez LD, Borruel M, Gates K, Starr S, Wagner GS. Related Articles Thrombolysis and Q wave versus non-Q wave first acute myocardial infarction: a GUSTO-I substudy. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries Investigators. J Am Coll Cardiol. 1997 Mar 15;29(4):770-7. PMID: 9091523 [PubMed - indexed for MEDLINE] 8: Sgarbossa EB, Pinski SL, Maloney JD. Related Articles The role of pacing modality in determining long-term survival in the sick sinus syndrome. Ann Intern Med. 1993 Sep 1;119(5):359-65. PMID: 8338288 [PubMed - indexed for MEDLINE] 9: Pinski SL, Maloney JD, Sgarbossa EB, Jubran F, Trohman RG. Related Articles Survival after a first episode of ventricular tachycardia or fibrillation. Pacing Clin Electrophysiol. 1992 Nov;15(11 Pt 2):2169-73. PMID: 1279620 [PubMed - indexed for MEDLINE] I'm an MD in the US, worked as a doc in Argentina |
| |